Manufacturer's Monthly
AUGUST 15, 2023
Global pharmaceutical and biotechnology company Moderna has opened its Regional Research Centre and Headquarters in Melbourne, which will unlock new advances and boost Victoria’s mRNA industry. billion investment in medical research since 2014. The Victorian state government invested $12.3
AU Manufacturing
JULY 6, 2023
Pharmaceutical company Cann Group Limited announced its FY23 unaudited results, with its operating revenue expected to be approximately $13.5 Founded in 2014, Cann Group is the first Australian company to secure the necessary licences to undertake research and cultivate cannabis for human medicinal and research purposes.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
AU Manufacturing
AUGUST 8, 2022
The partnership will establish the Victorian mRNA Innovation Hub (VMIH) with Monash Institute of Pharmaceutical Sciences, Peter Doherty Institute for Infection and Immunity, the University of Melbourne, and Monash University. . Since 2014, the state government has invested over $1.3
Manufacturer's Monthly
OCTOBER 6, 2022
Victoria is responsible for nearly 60 per cent of Australia’s pharmaceutical exports – making it the state’s highest value advanced manufactured export. billion in medical research since 2014, which has helped create more than 100,000 direct and indirect full-time jobs in the state’s biotech sector.
Manufacturer's Monthly
SEPTEMBER 17, 2023
billion investment in medical research since 2014. Victoria is responsible for almost 60 per cent of Australia’s pharmaceutical exports – making it our highest-value advanced manufacturing export – and the biotech sector supports more than 100,000 full-time jobs. The Victorian Government invested $12.3
Canadian Manufacturing
MAY 25, 2023
It would see natural health products fall under the same category as pharmaceuticals when it comes to how they are monitored once they are on the market. They would be incorporated into Vanessa’s Law, which was passed in 2014 to improve the reporting of adverse health reactions.
MEM
DECEMBER 15, 2022
All over the world precious bodies of water are contaminated with micropollutants such as pesticides, pharmaceuticals, and PFAS chemicals. The core technology behind this game changing innovation was developed over 5 years by Oxyle’s CEO and co-founder, Dr. Fajer Mushtaq, during her doctoral research at ETH Zurich that commenced in 2014.
Expert insights. Personalized for you.
98 
Let's personalize your content